$18M sweet spot round size
Most of their 521 investments are in rounds between $5.1M and $25M
1984
Undisclosed raised $210M on September 6, 2023
Investors: GV, RA Capital Management, L.P., Lightstone Ventures, S.R. One Ltd and Atlas Venture
K36 Therapeutics, Inc. raised $70M on June 28, 2023
Investors: Nextech Invest, Bristol-Myers Squibb, UK, F-Prime Capital Partners and Atlas Venture
Pheon Therapeutics raised $68M on September 28, 2022
Investors: Research Corporation Technologies, Inc., Forbion, Brandon Capital Partners and Atlas Venture
Undisclosed raised $125M on September 12, 2022
Investors: SV Life Sciences, S.R. One Ltd, Lightstone Ventures, RA Capital Management, L.P. and Atlas Venture
Disc Medicine raised $54M on August 10, 2022
Investors: OrbiMed Advisors, Novo Holdings, 5AM Ventures, Arix Bioscience plc and Atlas Venture
Remix Therapeutics raised $70M on May 17, 2022
Investors: The Column Group, Foresite Capital, Surveyor Capital, ARCH Venture Partners, Casdin Capital, LLC and Atlas Venture
Sionna Therapeutics raised $110M on April 19, 2022
Investors: OrbiMed Advisors, RA Capital Management, L.P., T. Rowe Price and Atlas Venture
Be Biopharma raised $130M on April 14, 2022
Investors: Alta Partners, Takeda UK Limited, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, RA Capital Management, L.P. and Atlas Venture
TRIANA Biomedicines raised $110M on April 6, 2022
Investors: Logos Global Management, LP, Surveyor Capital, Lightspeed Venture Partners, RA Capital Management, L.P. and Atlas Venture
Arkuda Therapeutics raised $64M on February 10, 2022
Investors: Surveyor Capital, Mission BioCapital, Tekla Capital Management and Atlas Venture